Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
The P/S ratio is N/A as of 2026-10-06T19:42:27.401Z.
Calculation as of: 2026-10-06T19:42:27.401Z.
Quote observation: 2026-10-05T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
N/A
Market Cap
$554.05M
PS Ratio
30.27
TTM Avg
14.58
3Y Avg
5.61
5Y Avg
4.40
Market Cap
$577.15M
PS Ratio
10.67
TTM Avg
11.75
3Y Avg
7.55
5Y Avg
5.31
Market Cap
$538.80M
PS Ratio
2.25
TTM Avg
5.40
3Y Avg
94.65
5Y Avg
94.65
Market Cap
$535.91M
PS Ratio
535.91
TTM Avg
520.33
3Y Avg
228.10
5Y Avg
183.31
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MiniMed Group, Inc. (MMEDV) | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $554.05M | 30.27 | 14.58 | 5.61 | 4.40 |
| CorMedix Inc. (CRMD)vs › | $568.78M | 1.23 | 2.97 | 1053.54 | 1425.81 |
| Aquestive Therapeutics, Inc. (AQST)vs › | $577.15M | 10.67 | 11.75 | 7.55 | 5.31 |
| Monopar Therapeutics Inc. (MNPR)vs › | $539.25M | N/A | N/A | N/A | N/A |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $538.80M | 2.25 | 5.40 | 94.65 | 94.65 |
| OrthoPediatrics Corp. (KIDS)vs › | $582.87M | 2.31 | 1.86 | 2.98 | 5.39 |
| Shattuck Labs, Inc. (STTK)vs › | $535.91M | 535.91 | 520.33 | 228.10 | 183.31 |
| Fulgent Genetics, Inc. (FLGT)vs › | $583.49M | 1.80 | 2.02 | 2.17 | 2.12 |
| ProKidney Corp. (PROK)vs › | $529.60M | 647.43 | 390.36 | 569.23 | 569.23 |
The four-quarter calculation detail is unavailable for this stored observation.
The current P/S calculation cannot be reconciled from the stored quote and revenue inputs.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
P/S Ratio
N/A
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
